Market Outlook of United States Electrophysiology Devices 2025
Press
Release - 23 April 2018
Global
Research and Development News
--
.
.
Report
Description-
'
'
GlobalDatas new report, United States
Electrophysiology Devices Market Outlook to 2025, provides key market
data on the United States Electrophysiology Devices market. The
report provides value, in millions of US dollars, volume (in units)
and average prices (USD) within market segments -Electrophysiology
Ablation Catheters, Electrophysiology Diagnostic Catheters and
Electrophysiology Lab Systems.
'
'
The report also provides company shares and
distribution shares data for each of these market segments, and
global corporate-level profiles of the key market participants. Based
on the availability of data for the particular market and country,
information related to pipeline products, news and deals is available
in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size and company share data for Electrophysiology Devices market segments - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Electrophysiology Devices market.
- Global corporate-level profiles of key companies operating within the United States Electrophysiology Devices market.
- Key players covered include Abbott Laboratories, Medtronic plc, Biosense Webster Inc, and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size and company share data for Electrophysiology Devices market segments - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Electrophysiology Devices market.
- Global corporate-level profiles of key companies operating within the United States Electrophysiology Devices market.
- Key players covered include Abbott Laboratories, Medtronic plc, Biosense Webster Inc, and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
– More
Clear Details get Table of Contents
https://www.researchmoz.us/united-states-electrophysiology-devices-market-outlook-to-2025-report.html/toc
'
'
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Electrophysiology Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Electrophysiology Devices Market, United States 9
3.1 Electrophysiology Devices Market, United States, Revenue ($m), 2015-2025 9
3.1.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 11
3.1.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 13
3.1.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2015-2025 15
3.2 Electrophysiology Devices Market, United States, Volume (Units), 2015-2025 18
3.2.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2015-2025 20
3.2.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2015-2025 22
3.2.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2015-2025 24
3.3 Electrophysiology Devices Market, United States, Average Price ($), 2015-2025 27
3.4 Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), 2017 29
3.5 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2017 30
4 Overview of Key Companies in United States, Electrophysiology Devices Market 32
4.1 Biosense Webster Inc 32
4.1.1 Company Overview 32
4.2 Abbott Laboratories 32
4.2.1 Company Overview 32
4.3 Medtronic Plc 32
4.3.1 Company Overview 32
4.4 Boston Scientific Corp 32
4.4.1 Company Overview 32
4.5 Micropace EP Inc. 33
4.5.1 Company Overview 33
4.6 Fischer Imaging Corp 33
4.6.1 Company Overview 33
5 Electrophysiology Devices Market Pipeline Products 34
6 Financial Deals Landscape 35
6.1 Acquisition 35
6.1.1 NN Acquires Bridgemedica 35
6.1.2 Becton, Dickinson Acquires C. R. Bard for USD24 Billion 36
6.2 Debt Offerings 39
6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 39
6.3 Equity Offerings 41
6.3.1 Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants 41
6.3.2 BioSig Technologies Raises USD4.5 Million in Private Placement of Shares 43
6.3.3 MC10 Raises Funds through Private Placement of Shares 44
6.3.4 MRI Interventions Raises USD13.3 Million in Private Placement of Units 45
6.3.5 BioSig Technologies Raises USD4.3 Million in Private Placement of Shares 47
6.4 Venture Financing 48
6.4.1 MC10 Raises USD15 Million in Venture Financing 48
6.4.2 BioSig Technologies Raises USD2 Million in Venture Financing 49
6.4.3 MC10 Raises Additional USD2 Million in Venture Financing 50
6.4.4 MC10 Raises USD7.3 Million in Venture Financing 51
6.4.5 BioSig Technologies Raises USD1.6 Million in Venture Financing 52
7 Recent Developments 53
7.1 Corporate Communications 53
7.1.1 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board 53
7.1.2 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 53
7.1.3 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 53
7.1.4 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory 54
7.1.5 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 54
7.1.6 Nov 14, 2017: BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission 55
7.1.7 Nov 10, 2017: IP veteran Andrew Filler joins BioSig Technologies Board of Directors 55
7.1.8 Oct 25, 2017: Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors 56
7.1.9 Oct 11, 2017: BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer 56
7.1.10 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 57
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Electrophysiology Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Electrophysiology Devices Market, United States 9
3.1 Electrophysiology Devices Market, United States, Revenue ($m), 2015-2025 9
3.1.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 11
3.1.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 13
3.1.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2015-2025 15
3.2 Electrophysiology Devices Market, United States, Volume (Units), 2015-2025 18
3.2.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2015-2025 20
3.2.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2015-2025 22
3.2.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2015-2025 24
3.3 Electrophysiology Devices Market, United States, Average Price ($), 2015-2025 27
3.4 Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), 2017 29
3.5 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2017 30
4 Overview of Key Companies in United States, Electrophysiology Devices Market 32
4.1 Biosense Webster Inc 32
4.1.1 Company Overview 32
4.2 Abbott Laboratories 32
4.2.1 Company Overview 32
4.3 Medtronic Plc 32
4.3.1 Company Overview 32
4.4 Boston Scientific Corp 32
4.4.1 Company Overview 32
4.5 Micropace EP Inc. 33
4.5.1 Company Overview 33
4.6 Fischer Imaging Corp 33
4.6.1 Company Overview 33
5 Electrophysiology Devices Market Pipeline Products 34
6 Financial Deals Landscape 35
6.1 Acquisition 35
6.1.1 NN Acquires Bridgemedica 35
6.1.2 Becton, Dickinson Acquires C. R. Bard for USD24 Billion 36
6.2 Debt Offerings 39
6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 39
6.3 Equity Offerings 41
6.3.1 Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants 41
6.3.2 BioSig Technologies Raises USD4.5 Million in Private Placement of Shares 43
6.3.3 MC10 Raises Funds through Private Placement of Shares 44
6.3.4 MRI Interventions Raises USD13.3 Million in Private Placement of Units 45
6.3.5 BioSig Technologies Raises USD4.3 Million in Private Placement of Shares 47
6.4 Venture Financing 48
6.4.1 MC10 Raises USD15 Million in Venture Financing 48
6.4.2 BioSig Technologies Raises USD2 Million in Venture Financing 49
6.4.3 MC10 Raises Additional USD2 Million in Venture Financing 50
6.4.4 MC10 Raises USD7.3 Million in Venture Financing 51
6.4.5 BioSig Technologies Raises USD1.6 Million in Venture Financing 52
7 Recent Developments 53
7.1 Corporate Communications 53
7.1.1 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board 53
7.1.2 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 53
7.1.3 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 53
7.1.4 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory 54
7.1.5 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 54
7.1.6 Nov 14, 2017: BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission 55
7.1.7 Nov 10, 2017: IP veteran Andrew Filler joins BioSig Technologies Board of Directors 55
7.1.8 Oct 25, 2017: Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors 56
7.1.9 Oct 11, 2017: BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer 56
7.1.10 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 57
Comments
Post a Comment